Publication date: Jun 06, 2024
But further research may show benefits with different doses or for people with specific symptoms. Paxlovid, effective in preventing severe COVID-19, didn’t appear to help long-COVID patients in this single-center study.
| Concepts | Keywords |
|---|---|
| Clinical | Adds |
| Covid | Benefit |
| Day | Clear |
| Severe | Covid |
| Day | |
| Effective | |
| Finds | |
| Long | |
| Paxlovid | |
| Preventing | |
| Regimen | |
| Safe | |
| Severe | |
| Single | |
| Trial |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | VO | effective |
| disease | MESH | COVID-19 |
(Visited 1 times, 1 visits today)